Mark Massaro
Stock Analyst at BTIG
(3.58)
# 827
Out of 4,920 analysts
133
Total ratings
50.86%
Success rate
21.02%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Buy | $60 | $57.74 | +3.91% | 1 | Apr 21, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $8 → $9 | $11.05 | -18.55% | 5 | Dec 18, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $65 → $75 | $47.36 | +58.36% | 16 | Nov 26, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $3.05 | - | 8 | Sep 10, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.2 → $7 | $14.28 | -50.98% | 6 | Aug 23, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $5.64 | +24.11% | 1 | Aug 16, 2024 | |
| ZTS Zoetis | Maintains: Buy | $220 → $225 | $146.12 | +53.98% | 2 | Aug 12, 2024 | |
| NTRA Natera | Maintains: Buy | $125 → $135 | $140.12 | -3.65% | 13 | Aug 9, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $35 → $45 | $106.65 | -57.81% | 4 | Jul 31, 2024 | |
| GH Guardant Health | Maintains: Buy | $45 → $50 | $46.17 | +8.30% | 2 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $641.94 | -9.65% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $5.62 | +273.67% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $2.05 | +290.24% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.30 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $2.49 | +221.29% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.42 | +133.92% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $20.35 | +47.42% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $8.87 | -43.63% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $12.85 | +94.55% | 2 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.28 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3.5 | $1.00 | +250.00% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $97.76 | +206.87% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $67.84 | -26.29% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $173.27 | -35.36% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $263.48 | -37.38% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $23.68 | +237.84% | 9 | Sep 10, 2018 |
Tempus AI
Apr 21, 2025
Initiates: Buy
Price Target: $60
Current: $57.74
Upside: +3.91%
Adaptive Biotechnologies
Dec 18, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $11.05
Upside: -18.55%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $65 → $75
Current: $47.36
Upside: +58.36%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.05
Upside: -
Ginkgo Bioworks Holdings
Aug 23, 2024
Maintains: Sell
Price Target: $0.2 → $7
Current: $14.28
Upside: -50.98%
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $5.64
Upside: +24.11%
Zoetis
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $146.12
Upside: +53.98%
Natera
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $140.12
Upside: -3.65%
GeneDx Holdings
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $106.65
Upside: -57.81%
Guardant Health
Jul 30, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $46.17
Upside: +8.30%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $641.94
Upside: -9.65%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $5.62
Upside: +273.67%
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $2.05
Upside: +290.24%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.30
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $2.49
Upside: +221.29%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $3.42
Upside: +133.92%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $20.35
Upside: +47.42%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $8.87
Upside: -43.63%
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $12.85
Upside: +94.55%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.28
Upside: -
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.00
Upside: +250.00%
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $97.76
Upside: +206.87%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $67.84
Upside: -26.29%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $173.27
Upside: -35.36%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $263.48
Upside: -37.38%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $23.68
Upside: +237.84%